USD 4.46
(-4.9%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -28.63 Million USD | 66.16% |
2022 | -84.6 Million USD | -51.89% |
2021 | -55.7 Million USD | -696.74% |
2020 | -6.99 Million USD | 59.0% |
2019 | -17.05 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -2.24 Million USD | 60.95% |
2024 Q1 | -5.74 Million USD | -85.35% |
2023 Q3 | -7.88 Million USD | -17.37% |
2023 FY | -28.63 Million USD | 66.16% |
2023 Q4 | -3.1 Million USD | 60.66% |
2023 Q2 | -6.71 Million USD | 38.96% |
2023 Q1 | -11 Million USD | 46.86% |
2022 Q4 | -20.7 Million USD | 5.14% |
2022 Q3 | -21.82 Million USD | -6.97% |
2022 Q1 | -21.69 Million USD | 34.85% |
2022 FY | -84.6 Million USD | -51.89% |
2022 Q2 | -20.4 Million USD | 5.97% |
2021 Q1 | -2.84 Million USD | 15.54% |
2021 Q4 | -33.3 Million USD | -141.99% |
2021 Q3 | -13.76 Million USD | -135.11% |
2021 FY | -55.7 Million USD | -696.74% |
2021 Q2 | -5.85 Million USD | -105.51% |
2020 Q1 | -1.87 Million USD | 0.0% |
2020 Q4 | -3.37 Million USD | -201.34% |
2020 Q3 | -1.11 Million USD | -79.61% |
2020 Q2 | -623 Thousand USD | 66.81% |
2020 FY | -6.99 Million USD | 59.0% |
2019 FY | -17.05 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Abbott Laboratories | 6.47 Billion USD | 100.442% |
Allurion Technologies Inc. | -78.07 Million USD | 63.329% |
Artivion, Inc. | 5.74 Million USD | 598.642% |
Avanos Medical, Inc. | 4.2 Million USD | 781.714% |
Butterfly Network, Inc. | -145.61 Million USD | 80.337% |
Butterfly Network, Inc. | -145.61 Million USD | 80.337% |
Bio-Rad Laboratories, Inc. | 383.79 Million USD | 107.46% |
Boston Scientific Corporation | 2.34 Billion USD | 101.222% |
Perspective Therapeutics, Inc. | -15.18 Million USD | -88.592% |
CONMED Corporation | 130.78 Million USD | 121.892% |
Edwards Lifesciences Corporation | 1.53 Billion USD | 101.866% |
Paragon 28, Inc. | -37.3 Million USD | 23.257% |
Glaukos Corporation | -128.7 Million USD | 77.753% |
Globus Medical, Inc. | 133.14 Million USD | 121.505% |
Inspire Medical Systems, Inc. | -40.27 Million USD | 28.902% |
Integer Holdings Corporation | 167.33 Million USD | 117.111% |
Medtronic plc | 5.14 Billion USD | 100.557% |
Nevro Corp. | -99.3 Million USD | 71.168% |
Penumbra, Inc. | 73.55 Million USD | 138.928% |
Vicarious Surgical Inc. | -80.66 Million USD | 64.505% |
Smith & Nephew plc | 425 Million USD | 106.737% |
Sonendo, Inc. | -57.74 Million USD | 50.415% |
STERIS plc | 836.11 Million USD | 103.424% |
Stryker Corporation | 3.88 Billion USD | 100.736% |
Vapotherm, Inc. | -39.08 Million USD | 26.735% |
Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 102.241% |